Table 2.
1 | Nitroglycerin | Claim | An optimal clinical response for improved quality of life (Qol) |
Analysis | (i) Claim did not specify the type/kind of clinical response and how it improved the quality of life (ii) No reference cited in support |
||
| |||
2 | Combination of carbonyl iron/vitamin B12/vitamin C/vitamin E/folic acid/sodium selenite/copper sulphate and zinc sulphate | Claim | Slow rate of solubilization resulting in gentle absorption |
Analysis | (i) No pharmaceutical data provided (ii) No reference mentioned in support |
||
| |||
3 | Chlorothiazide plus Telmisartan | Claim | C the difference with better partner |
Analysis | (i) Incomprehensible phrase without any reference quoted in support | ||
| |||
4 | Ivabradine | Claim | Decrease the need for hospitalizations, emergency services, and sick leaves versus usual care |
Analysis | (i) Unable to explain how the referred drug decreased the morbidity (ii) Irretrievable reference in support |
||
| |||
5 | Esomeprazole | Claim | The most prescribed proton pump inhibitor (PPI) worldwide |
Analysis | (i) Vague claim without any reference |